» Articles » PMID: 29170607

How Outpatient Substance Abuse Treatment Unit Director Activities May Affect Provision of Community Outreach Services

Overview
Publisher Informa Healthcare
Specialty Medical Education
Date 2017 Nov 25
PMID 29170607
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Community outreach services play an important role in infectious disease prevention and engaging drug users not currently in treatment. However, fewer than half of US substance abuse treatment units provide these services and many have little financial incentive to do so. Unit directors generally have latitude about scope of services, including the level of outreach provided to the community. The current study examines how directors' interactions with external stakeholders affect substance abuse treatment units' provision of community outreach services.

Methods: Cross-sectional logistic and Poisson regression analyses were conducted on a national sample of US outpatient substance abuse treatment units ( = 547).

Results: Findings suggest that the amount of time directors spent with licensing and monitoring associations was associated with provision of a greater number of community outreach services, while time spent with professional and occupational associations was associated with provision of off-site human immunodeficiency virus and hepatitis C testing. Several other director attributes and organizational characteristics also emerged as significant.

Conclusions: External stakeholders with whom substance abuse treatment directors interact may influence community outreach through their effects on treatment directors' strategic priorities. Implications for policy and prevention efforts are discussed.

Citing Articles

Organizational supports used by private child and family serving agencies to facilitate evidence use: a mixed methods study protocol.

Chuang E, Collins-Camargo C, McBeath B Implement Sci. 2017; 12(1):49.

PMID: 28390421 PMC: 5385079. DOI: 10.1186/s13012-017-0580-1.


The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs.

Frimpong J, Shiu-Yee K, DAunno T Health Serv Res. 2016; 52(5):1881-1907.

PMID: 27618580 PMC: 5583309. DOI: 10.1111/1475-6773.12558.


Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.

Frimpong J, DAunno T Subst Abuse Treat Prev Policy. 2016; 11:13.

PMID: 27036115 PMC: 4818491. DOI: 10.1186/s13011-016-0057-2.

References
1.
. Twenty-five years of HIV/AIDS--United States, 1981-2006. MMWR Morb Mortal Wkly Rep. 2006; 55(21):585-9. View

2.
Hagan H, Thiede H, Weiss N, Hopkins S, Duchin J, ALEXANDER E . Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001; 91(1):42-6. PMC: 1446500. DOI: 10.2105/ajph.91.1.42. View

3.
Haynes L, Korte J, Holmes B, Gooden L, Matheson T, Feaster D . HIV rapid testing in substance abuse treatment: implementation following a clinical trial. Eval Program Plann. 2011; 34(4):399-406. PMC: 3124222. DOI: 10.1016/j.evalprogplan.2011.02.007. View

4.
Alexander J, Wells R, Jiang L, Pollack H . Organizational determinants of boundary spanning activity in outpatient substance abuse treatment programmes. Health Serv Manage Res. 2008; 21(3):168-77. PMC: 5699468. DOI: 10.1258/hsmr.2007.007028. View

5.
Ducharme L, Mello H, Roman P, Knudsen H, Johnson J . Service delivery in substance abuse treatment: reexamining "comprehensive" care. J Behav Health Serv Res. 2007; 34(2):121-36. DOI: 10.1007/s11414-007-9061-7. View